FDA NDC Directory · JSON-LD · Markdown

Cytarabine

NDC 68083-337 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA211938
Dosage form / routeINJECTION, SOLUTION · INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Active ingredientsCYTARABINE (100 mg/mL)
Marketing started20191223
Package count1

External sources

Source: openFDA. Public-domain (CC0).